Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension

Código QR

Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension

Pulmonary arterial hypertension (PAH), group 1 pulmonary hypertension (PH), is a fatal disease that is characterized by vasoconstriction, increased pressure in the pulmonary arteries, and right heart failure. PAH can be described by abnormal vascular remodeling, hyperproliferation in the vasculature...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mazen Shihan, Tatyana Novoyatleva, Thilo Lehmeyer, Akylbek Sydykov, Ralph T. Schermuly
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	pulmonary arterial hypertension purinergic P2Y2 receptor pharmacological approach Medicine R
Acceso en línea:	https://doaj.org/article/cb85d7240ad242738d67aa549ac4c268
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
por: Luis Regalado, BS, MSc, et al.
Publicado: (2022)

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
por: Engel T, et al.
Publicado: (2021)

Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection
por: Victor H. Leyva-Grado, et al.
Publicado: (2017)

CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia–reperfusion injury in vivo and in vitro
por: Yun Ding, et al.
Publicado: (2021)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Su-Gang Gong, et al.
Publicado: (2021)

Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
por: Paulien Vinke, et al.
Publicado: (2021)

Pulmonary Hypertension in the Dog
por: Poser Helen, et al.
Publicado: (2016)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
por: Anton A. Shmalts, et al.
Publicado: (2021)

Purinergic Signaling in the Regulation of Gout Flare and Resolution
por: Xiaoling Li, et al.
Publicado: (2021)

Pulmonary hypertension in left heart disease
por: Pratishtha Mehra, et al.
Publicado: (2018)

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
por: Irina E. Chazova, et al.
Publicado: (2020)

The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis
por: Bei Xu, et al.
Publicado: (2021)

Expanding the Evidence of a Semi-Dominant Inheritance in <i>GDF2</i> Associated with Pulmonary Arterial Hypertension
por: Natalia Gallego, et al.
Publicado: (2021)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Yong-Jie Chen, et al.
Publicado: (2021)

PURINERGIC REGULATION OF BASIC PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES
por: A. S. Golovkin, et al.
Publicado: (2018)

Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine
por: Clémentine Dillard, et al.
Publicado: (2021)

Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients
por: Mei-Tzu Wang, et al.
Publicado: (2021)

Construction of a Support Vector Machine–Based Classifier for Pulmonary Arterial Hypertension Patients
por: Zhenglu Shang, et al.
Publicado: (2021)

Exercise-Induced Pulmonary Hypertension: How to Define, Diagnose, and Treat At-Risk Patients
por: Brandon Shokoples, et al.
Publicado: (2021)

A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment
por: Ma RZ, et al.
Publicado: (2021)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
por: Panagiota Xanthouli, et al.
Publicado: (2021)

Prognostic implications of pulmonary wave reflection and reservoir pressure in patients with pulmonary hypertension
por: K. Wustmann, et al.
Publicado: (2021)

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios K, et al.
Publicado: (2016)

Pulmonary hypertension in patients with hemodynamically significant atherosclerotic lesion of a common carotid artery: new pathophysiological mechanisms of the disease
por: M. A. Markov, et al.
Publicado: (2020)

Assessing the spectrum of pulmonary hypertension identified at an Egyptian expert referral center
por: Mostafa Elshazly, et al.
Publicado: (2021)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
por: Alexander V. Sobolev, et al.
Publicado: (2021)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Abraham Tettey, et al.
Publicado: (2021)

Hipertensión pulmonar y embarazo
por: Valdés S,Gloria, et al.
Publicado: (2002)

Measurement of Pulmonary Artery Wave Reflection Before and After Mitral Valvuloplasty in Canine Patients With Pulmonary Hypertension Caused by Myxomatous Mitral Valve Disease
por: Tomohiko Yoshida, et al.
Publicado: (2021)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Zhifeng Xue, et al.
Publicado: (2021)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu H, et al.
Publicado: (2021)

Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future
por: Tamila V. Martynyuk, et al.
Publicado: (2021)

Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension
por: Fan Zhang, et al.
Publicado: (2021)

Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension
por: Vazhma Qaderi, et al.
Publicado: (2021)

THE INFLUENCE OF CONCOMITANT CARDIOVASCULAR PATHOLOGY (ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION) ON THE CHANGES OF RIGHT VENTRICLE OF HEART IN MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
por: O. Yu. Korotenko, et al.
Publicado: (2012)

Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study
por: Makoto Shoji, et al.
Publicado: (2021)

Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model
por: Liu K, et al.
Publicado: (2016)

Predictors of pulmonary hypertension among children with atrial septal defects (ASD)
por: Josephat M Chinawa, et al.
Publicado: (2022)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Jaylen Hudson, et al.
Publicado: (2021)

Are statins beneficial for the treatment of pulmonary hypertension?
por: Lei Wang, et al.
Publicado: (2017)